A new AI platform offers free drug discovery tools to global health researchers, aiming to speed up treatments for malaria, ...

As the AI era becomes increasingly shaped by foundation models, the pharmaceutical industry is entering a new phase of opportunity for discovery, design, and decision-making driven by AI for science.

While precision seems critical for science, researchers from the U.S. Department of Energy's (DOE) Brookhaven National ...

Our Bureau, New Delhi Monday, April 6, 2026, 14:15 Hrs [IST] The Department of Pharmaceuticals (DoP) organised a webinar on “AI a ...

What began as a child's encounter with trauma has grown into a research programme committed to understanding recovery.

Through this partnership, Aptar Digital Health will deliver a companion digital solution for Enable Injections’ enFuse ® system, designed to enhance the patient experience and support adherence. Key ...

Luka Doncic dragged his hamstring through an entire half of basketball last Thursday against the Thunder, tugging at it ...

AI supercomputers market to reach 2.86 billion dollars by 2030, driven by generative AI, healthcare breakthroughs, and chip ...

LC: Manufacturability is the field's most critical near-term challenge, especially for ex vivo cell therapies. Encouragingly, ...

Stacker used an index that equally weighs IMDb score and Rotten Tomatoes critic ratings to rank the best science fiction film ...

In the announcement, FDA Commissioner Mackary said, “Bayesian methodologies help address two of the biggest problems of drug ...